---
title: "Resource Overlap and Reporting of Independence in Public Prostate Cancer Data"
id: "medrxiv-7-resource-overlap-and-reporting-of-independence-in-public-prostate-cancer"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-7-resource-overlap-and-reporting-of-independence-in-public-prostate-cancer"
content_type: "clinical_feed_article"
specialty: "Oncology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.10.26362786v1?rss=1"
published_at: "2026-09-12T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Resource Overlap and Reporting of Independence in Public Prostate Cancer Data
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-7-resource-overlap-and-reporting-of-independence-in-public-prostate-cancer
- **Specialty:** [Oncology](https://medichelpline.com/clinical-feed/oncology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.10.26362786v1?rss=1)
- **Published At:** 2026-09-12T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Public prostate cancer datasets can represent overlapping patients, specimens, or sample records across different repository identifiers or releases, creating potential nonindependence among resources. - The authors conducted a cross-sectional methodological audit of selected public prostate cancer repositories and related publications, reconciling resource records through September 2, 2026, with adjudication to September 8, 2026. - The frame comprised 189 repository study records and 108 publication/version records, yielding 230 publication-resource-pair records for assessment. - A combination of language-model extraction, targeted original-source checks, deterministic classification, and manual verification in September 2026 was used to identify supported relations. - The audit identified 101 supported resource pairs: 97 showing direct patient, specimen, or sample-record identity; 1 showing component containment; and 3 with study/source nonindependence. - Among 108 publication/version records, 8 (6 journal articles and 2 preprint versions) used related resources in analyses that required independence but did not report applicable **overlap controls**. - An additional 3 publications reported applicable overlap controls; 16 publications retained reporting gaps; and 81 publications did not meet the qualifying use or relation criteria. - In one flagged publication, 45 shared sample identifiers were found across two validation sheets, corroborating sample-record reuse though not confirming donor identity. - The audit did not reanalyze published results and did not establish a global independent-patient total or prevalence estimate. - Authors conclude that **resource nonindependence** coexists with absent claim-specific control reporting and recommend provenance-aware use and explicit reporting; no competing interests were declared. - Supplementary workbook includes derived resource tables and publication-level audit summaries; complete versioned files and SHA-256 manifests are retained pending repository deposition.
## Clinical Analysis & Structured Key Points
Importance Public prostate cancer data may appear under different repository identifiers or releases while representing overlapping patients, specimens, or sample records. The implications for reported analytic independence require assessment at both resource and publication levels. Objective To characterize supported nonindependence among selected public prostate cancer resources and assess reported overlap control in publications using related resources. Design Cross-sectional methodological audit. Resource records were reconciled through September 2, 2026; recovery of retained sources and adjudication continued through September 8, 2026. Language-model extraction and targeted original-source checks informed deterministic classification. The authors manually verified all positive findings, including supplementary materials, in September 2026. Setting Public prostate cancer repositories and Europe PMC and PubMed retrieval, with a publication cutoff of August 15, 2026. Participants A nonrepresentative frame of 189 repository study records and 108 publication/version records contributing 230 publication-resource-pair records. Exposures Analytic use of both endpoints of a confirmed resource relation in the same linked claim. Main Outcomes and Measures Supported identity levels and resolvable patient-identifier counts; reported overlap control when linked analyses required independent records. Unresolved evidence was retained separately. Published results were not reanalyzed. Results The audit identified 101 supported resource pairs: 97 with direct patient, specimen, or sample-record identity, 1 with component containment, and 3 with study/source nonindependence. Among 108 publication/version records, 8 (6 journal articles and 2 preprint versions) used related resources in analyses requiring independence without reporting applicable overlap controls. Another 3 reported applicable controls, 16 retained reporting gaps, and 81 fell outside the qualifying use or relation criteria. One of the 8 had 45 shared sample identifiers in two validation sheets, corroborating sample-record reuse but not donor identity. No global independent-patient total or prevalence estimate was established. Conclusions and Relevance Resource nonindependence coexisted with absent claim-specific control reporting, with direct sample-record corroboration in one publication. The findings support provenance-aware use and explicit reporting, without establishing effects on published results.
## Related Clinical Research

- [Satisfaction with Treatment Decision-Making and Long-Term Experiences in mCRPC Life-Prolonging The](https://medichelpline.com/clinical-feed/pubmed-42760521.md) (DOI: 10.1186/s12904-026-02336-1)
- [Exosomal circular RNAs and their roles in the tumor immune microenvironment](https://medichelpline.com/clinical-feed/pubmed-42757479.md) (DOI: 10.3892/ijmm.2026.5989)
- [Cancer type–specific chromatin regulator mutations linked to better survival after immune checkpoi](https://medichelpline.com/clinical-feed/medrxiv-17-cancer-type-specific-profiling-of-chromatin-regulator-mutations-identifies.md)
- [Healthy lifestyle and pan-cancer risk: UK Biobank prospective analysis](https://medichelpline.com/clinical-feed/british-journal-of-cancer-2-healthy-lifestyle-and-cancer-risk-a-pan-cancer-analysis-in-the-uk-biobank.md)
- [Molecular Editing Produces an NSD2-Selective PROTAC and a GSPT1-Selective Molecular Glue](https://medichelpline.com/clinical-feed/biorxiv-23-molecular-editing-in-protein-degradation-from-a-dual-nsd2-gspt1-degrader-to-an.md)

## Navigation
- [← Back to Oncology Feed](https://medichelpline.com/clinical-feed/oncology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.